The U.S. Securities and Exchange Commission filed insider trading charges against Usama Malik, the former chief financial officer of Immunomedics Inc.
The Securities and Exchange Commission (SEC) is charging Matthew Panuwat – a former business development executive at Medivation – with insider trading, according to a complaint filed in court stemming from Pfizer’s acquisition of Medivation in 2016.
